Oral-Parenteral Conversion Factor for Morphine in Palliative Cancer Care: A Prospective Randomized Crossover Pilot Study
Pain Research and Treatment · 2011
DOI: 10.1155/2011/504034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Research and Treatment, 2011. Verfasst von Jan Starlander und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Östersund Hospital, 831 83 Östersund, Sweden. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
This pilot study clinically tests whether a conversion factor of 2 to 1 is appropriate when changing from oral to parenteral morphine administration in the treatment of cancer-related nociceptive pain and calculates the size of an adequately powered future study.
Methods
Eleven outpatients with incurable cancer and well-controlled nociceptive pain were randomly assigned to either intravenous or subcutaneous morphine using half the previous oral 24-hour dose. Each group crossed over after the first three-day period. Serum concentrations of morphine and its metabolites were monitored as well as intensity of pain.
Results
Oral to subcutaneous and oral to intravenous quotas of morphine concentrations were approximately 0.9. Subcutaneous to intravenous morphine quotas were 1.
Conclusions
The conversion factor of 2 to 1 seems to be a reasonable average but with an obvious need for individual adjustments. Concurrent medications and substantially higher doses of morphine could potentially affect the appropriate conversion factor. An adequately powered study to validate these findings would need at least 121 patients.
Autor:innen und Institutionen
- Department of Internal Medicine, Östersund Hospital, 831 83 Östersund, Sweden.
Zitieren
APA
Starlander, J., Melin-Johansson, C., Jonsson, H., & Axelsson, B. (2011). Oral-Parenteral Conversion Factor for Morphine in Palliative Cancer Care: A Prospective Randomized Crossover Pilot Study. Pain Research and Treatment. https://doi.org/10.1155/2011/504034
Vancouver
Starlander J, Melin-Johansson C, Jonsson H, Axelsson B. Oral-Parenteral Conversion Factor for Morphine in Palliative Cancer Care: A Prospective Randomized Crossover Pilot Study. Pain Research and Treatment. 2011. doi:10.1155/2011/504034
BibTeX
@article{Starlander2011,
author = {Starlander, Jan and Melin-Johansson, Christina and Jonsson, Håkan and Axelsson, Bertil},
title = {Oral-Parenteral Conversion Factor for Morphine in Palliative Cancer Care: A Prospective Randomized Crossover Pilot Study},
journal = {Pain Research and Treatment},
year = {2011},
doi = {10.1155/2011/504034}
}
EUVIMED